Categories: All posts

Li Ka-shing increases investment in WELL Health as coronavirus fears heighten

He doesn’t often make investments in North America, but when he does they are usually home runs.

Hong Kong billionaire and philanthropist Li Ka-shing has upped his investment into Canadian telehealth and next-gen clinic player WELL Health Technologies (WELL Health Technologies Stock Quote, Chart, News TSX:WELL).

Li put another million dollars into WELL via a recent convertible debenture financing of $11-million. The investment brings his ownership of the Canadian healthcare upstart to approximately 18 per cent, part of which was made through his venture capital firm, Horizons Ventures.

“We are excited to include participation from Mr. Li Ka-shing in this financing,” WELL CEO Hamed Shahbazi said of the development. “We are appreciative of the support we have received from both the institutional investor and Mr. Li Ka-shing. This financing provides Well with sufficient capital to continue to grow its clinical, digital and virtual service offerings.”

Estimated to be worth $30-billion, Li’s empire encompasses real estate, manufacturing, the A.S. Watson Group, (which owns Watsons, the largest health care and beauty care chain in Asia), Canada’s Husky Energy, and investments in American tech stalwarts Facebook and Spotify.

WELL Health has been active in 2020. Earlier this month, the company announced it had launched VirtualClinic+, a digital health communications platform that connects patients to physicians through video, phone and secure messaging. On Friday, the company issued a statement, noting that it has already activated approximately 40 doctors on VirtualClinic+ with another 60 set to be added in the coming days.

WELL Health Technologies CEO Hamed Shahbazi

Then, on March 10, the company announced a flu surveillance partnership with McMaster University and the Public Health Agency of Canada that would see the company leverage its already extensive network of Canadian doctors.

“Our networks of paediatricians and family doctors are essential to surveillance,” said Dr. Theresa Tam, chief public health officer of Canada. “They are the front line of primary care and are often the first to detect new or unexpected patterns of illness that alert us to a potential problem. By working with partners to build tools like this, we can better support physician reporting and improve future surveillance of influenza-like illness.”

As of Monday, there were 370 presumptive and confirmed cases of COVID-19 in Canada, with one confirmed death.

“Our window to flatten the curve of the epidemic is narrow,” Tam warned on Sunday. “We all need to act now. COVID-19 is a serious public health threat.”

Disclosure: Cantech Letter’s Nick Waddell and Jayson MacLean own shares of WELL Health Technologies and the company is an annual sponsor of Cantech Letter.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: well
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Should you buy AMZN? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Amazon (Amazon Stock… [Read More]

16 hours ago

These cannabis stocks will benefit most from reclassification

It happened. The move that everyone in the cannabis sector was hoping for came about swiftly on the last day… [Read More]

22 hours ago

Is AMD stock a buy? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Suji Desilva has maintained his "Buy" rating on Advanced Micro Devices… [Read More]

23 hours ago

Is Wolfspeed stock still a buy?

Ahead of the company's third quarter results, Roth MKM analyst Scott Irwin has maintained his "Buy" rating on Wolfspeed (Wolfspeed… [Read More]

24 hours ago

WELL Health inks five-year deal with Microsoft

It's become one of the biggest players in the Canadian healthcare space, now WELL Health (WELL Health Stock Quote, Chart,… [Read More]

2 days ago

Is Thomson Reuters stock a buy right now?

Its stock has made a since last October, but is there more upside left in Thomson Reuters (Thomson Reuters Stock… [Read More]

2 days ago